SNORD38B: A Potential Drug Target and Biomarker (G94163)

Target Name: SNORD38B

NCBI ID: G94163

SNORD38B

Other Name(s): Small nucleolar RNA, C/D box 38B | U38B | RNU38B | small nucleolar RNA, C/D box 38B

SNORD38B: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA) is a class of RNA molecules that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the most well-studied snRNAs is SNORD38B, which is located in the C/D box region of the 38th chromosome. In this article, we will discuss the potential implications of SNORD38B as a drug target and biomarker.

The C/D box region of the 38th chromosome is a highly conserved region that contains a variety of non-coding RNAs, including snRNAs. SNORD38B is one of the most well-studied snRNAs in the C/D box region. It is located at position 618.5 on the 38th chromosome and has a length of 212 nucleotides. SNORD38B is characterized by the presence of a stem-loop and a loop region, as well as a unique fMetbox modification at its 3' end.

SNORD38B is involved in the regulation of gene expression in various cell types, including neurons, heart cells, and cancer cells. It has been shown to play a role in the regulation of neuronal differentiation, synaptic plasticity, and stress resistance. In addition, SNORD38B has also been shown to play a role in the regulation of cell cycle progression, apoptosis, and metabolism.

As a potential drug target, SNORD38B has the potential to intervene in a wide range of cellular processes that are important for human health and disease. For example, SNORD38B has been shown to be involved in the regulation of neuronal communication, which is important for learning and memory. Therefore, drugs that can modulate SNORD38B activity may have potential applications in treating a wide range of neurological and psychiatric disorders.

In addition to its potential as a drug target, SNORD38B also has the potential as a biomarker. The expression of SNORD38B has been shown to be regulated by various factors, including DNA methylation, histone modification, and post-transcriptional modifications. Therefore, the expression level of SNORD38B can be used as a biomarker for a wide range of cellular processes, including neuronal function, stress response, and metabolism.

SNORD38B has also been shown to play a role in the regulation of cellular signaling pathways that are important for human health and disease. For example, SNORD38B has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in cell survival and metabolism. Therefore, drugs that can modulate SNORD38B activity may have potential applications in treating a wide range of diseases, including cancer, neurodegenerative disorders, and metabolic disorders.

In conclusion, SNORD38B is a well-studied snRNA that is involved in the regulation of gene expression in various cell types. Its unique structure and function make it an attractive potential drug target and biomarker. Further research is needed to fully understand the role of SNORD38B in cellular processes and its potential as a therapeutic agent.

Protein Name: Small Nucleolar RNA, C/D Box 38B

The "SNORD38B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD38B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets